Safety aspects of treatment with lacidipine—a slow-onset, long-acting calcium antagonist

LH Lindholm, P Tcherdakoff, A Zanchetti - Blood pressure, 1996 - Taylor & Francis
Objective: The aim was to review the clinical safety profile of lacidipine with the help of the
rather comprehensive datafile of the manufacturer-a novel approach which may be of some …
被引用次数：17 相关文章

Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist.

LH Lindholm, P Tcherdakoff, A Zanchetti - Blood Pressure, 1996 - europepmc.org
Objective The aim was to review the clinical safety profile of lacidipine with the help of the
rather comprehensive datafile of the manufacturer-a novel approach which may be of some …

Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist

LH Lindholm, P Tcherdakoff, A Zanchetti - Blood pressure, 1996 - pubmed.ncbi.nlm.nih.gov
Objective The aim was to review the clinical safety profile of lacidipine with the help of the
rather comprehensive datafile of the manufacturer-a novel approach which may be of some …

[引用][C] Safety aspects of treatment with lacidipine: A slow-onset, long-acting calcium antagonist

LH LINDHOLM, P TCHERDAKOFF… - Blood …, 1996 - pascal-francis.inist.fr
Safety aspects of treatment with lacidipine : A slow-onset, long-acting calcium antagonist
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

[引用][C] Safety aspects of treatment with lacidipine: A slow-onset, long-acting calcium antagonist

LH LINDHOLM, P TCHERDAKOFF… - Blood pressure, 1996 - Taylor & Francis